<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Genes &amp; Cells</journal-id><journal-title-group><journal-title xml:lang="en">Genes &amp; Cells</journal-title><trans-title-group xml:lang="ru"><trans-title>Гены и Клетки</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Genes and Cells</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-1829</issn><issn publication-format="electronic">2500-2562</issn><publisher><publisher-name xml:lang="en">Human Stem Cells Institute</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">121984</article-id><article-id pub-id-type="doi">10.23868/202104008</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The effect of antihistamines drugs on the functional activity of neutrophils</article-title><trans-title-group xml:lang="ru"><trans-title>Действие антигистаминных препаратов на функциональную активность нейтрофилов</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Plekhova</surname><given-names>N. G</given-names></name><name xml:lang="ru"><surname>Плехова</surname><given-names>Н. Г</given-names></name></name-alternatives><email>pl_nat@hotmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Dubnyak</surname><given-names>I. N</given-names></name><name xml:lang="ru"><surname>Дубняк</surname><given-names>И. Н</given-names></name></name-alternatives><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Eliseeva</surname><given-names>E. V</given-names></name><name xml:lang="ru"><surname>Елисеева</surname><given-names>Е. В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Pacific State Medical University Department of Health of Russian Federation</institution></aff><aff><institution xml:lang="ru">Тихоокеанский государственный медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Vladivostok Clinical Hospital № 2</institution></aff><aff><institution xml:lang="ru">Владивостокская клиническая больница № 2</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2021-03-15" publication-format="electronic"><day>15</day><month>03</month><year>2021</year></pub-date><volume>16</volume><issue>1</issue><issue-title xml:lang="en">VOL 16, NO1 (2021)</issue-title><issue-title xml:lang="ru">ТОМ 16, №1 (2021)</issue-title><fpage>53</fpage><lpage>59</lpage><history><date date-type="received" iso-8601-date="2023-01-16"><day>16</day><month>01</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, Эко-Вектор</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2024-03-15"/></permissions><self-uri xlink:href="https://genescells.ru/2313-1829/article/view/121984">https://genescells.ru/2313-1829/article/view/121984</self-uri><abstract xml:lang="en"><p>Allergic inflammation is accompanied by stimulation of neutrophils with an increase in the formation of reactive oxygen species. The antioxidant effectiveness of some antihistamines is known, which reduces the risk of damage to surrounding tissues with the participation of these cells. Objective of the study: to determine the degree of various generations antihistamines influence on the death and enzymatic activity of neutrophils. The effect of the first antihistamines (diphenhydramine, clemastine) and second (lorata-dine, desloratadine) generations and the hormonal drug dexameth-asone on cell viability, the formation of active oxygen metabolites, enzyme activity, the amount of cationic proteins, and cytokine production by neutrophils was studied using the in vitro model. It was found that after exposure to loratadine at a dose of 2.5 |jg / ml, the number of viable cells was comparable (p = 0.001) with that in an intact culture. Found a stimulating effect of second generation antihistamines (loratadine, desloratadine) in low doses on the activity of NADPH-dependent oxide reductase. The form of neutrophil death depended on the type and dose of the drug; apoptosis was predominantly observed after cell contact with loratadine and desloratadine. Against the background of an increase in the activity of ATPase and myeloperoxidase after contact with diphenhydramine and clemastine (2.5 jg / ml), the largest number of neutrophils producing reactive oxygen species was revealed. Under the influence of desloratodine and clemastine, exocytosis of cationic proteins into the extracellular space and the lowest production of cytokines after contact with the latter were established. Thus, exposure to Hl-antihistamines, active both extra- and intracellular (diphenhydramine, loratadine), probably disrupted the metabolism of neutrophils, which led to an increase in their killer potential. Clemastine, acting mainly extracellularly, minimized the toxic effects of extracellular radicals, without affecting the production of intracellular oxidants involved in the regulation of neutrophil functions.</p></abstract><trans-abstract xml:lang="ru"><p>Аллергическое воспаление сопровождается стимуляцией нейтрофилов с увеличением образования активных форм кислорода. Известна антиоксидантная эффективность некоторых антигистаминных препаратов, что снижает риск повреждения окружающих тканей при участии этих клеток. Цель исследования: определить степень влияния антигистаминных препаратов различных поколений на гибель и ферментативную активность нейтрофилов. На модели «in vitro» изучали воздействие антигистаминных препаратов первого (димедрола, клемастина) и второго (лоратадина, дезлоратадина) поколений и гормонального препарата дексаметазона на жизнеспособность клеток, образование активных метаболитов кислорода, активность ферментов, количество катионных белков и продукцию цитокинов нейтрофилами. Установлено, что после воздействия лоратадина в дозе 2,5 мкг/мл количество жизнеспособных клеток было сопоставимо (р=0,001) с таковым в интактной культуре. Обнаружен стимулирующий эффект антигистаминных препаратов второго поколения (лоратадин, дезлоратадин) в низких дозах на активность НАДФН-зависимой оксидоредуктазы. Форма гибели нейтрофилов зависела от вида и дозы препарата, апоптоз преимущественно был отмечен после контакта клеток с лоратадином и дезлоратадином. На фоне повышения активности АТФазы и миелопероксидазы после контакта с димедролом и клемастином (2,5 мкг/мл) было выявлено наибольшее количество нейтрофилов, продуцирующих активные формы кислорода. Под действием дезлоратодина и клемастина установлен экзоцитоз катионных белков во внеклеточное пространство и наименьшая продукция цитокинов после контакта с последним. Таким образом, воздействие H1-антигистаминных препаратов, активных как вне-, так и внутриклеточно (димедрол, лоратадин), вероятно, нарушало метаболизм нейтрофилов, что приводило к повышению их киллерного потенциала. Клемастин, воздействуя преимущественно внеклеточно, минимизировал токсические эффекты внеклеточных радикалов, не влияя на выработку внутриклеточных окислителей, участвующих в регуляции функций нейтрофилов.</p></trans-abstract><kwd-group xml:lang="en"><kwd>allergic diseases</kwd><kwd>antihistamines</kwd><kwd>neutrophils</kwd><kwd>reactive oxygen species</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>аллергические заболевания</kwd><kwd>антигистаминные препараты</kwd><kwd>нейтрофилы</kwd><kwd>активные формы кислорода</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Akdis C.A., Simons F.E.R. Histamine receptors are hot in immuno-pharmacology. Eur. J. Pharmacol. 2006; 533: 69-76.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Soldner C.A., Horn A.H.C., Sticht Н. Binding of histamine to the Н1 receptor-a molecular dynamics study. J. Mol. Model. 2018; 24(12): 346-52.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Church M.K., Church D.S. Pharmacology of antihistamines. Indian. J. Dermatol. 2013; 58(3): 219-24.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Fukui Н., Mizuguchi Н., Nemoto Н. et al. Histamine H, receptor gene expression and drug action of antihistamines. Handb. Exp. Pharmacol. 2017; 241: 161-9.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Randall K.L., Hawkins C.A. Antihistamines and allergy. Aust. Prescr. 2018; 41(2): 41-5.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Canonica G.W., Blaiss M. Antihistaminic, anti-inflammatory, and antiallergic properties of the nonsedating second-generation antihistamine desloratadine: a review of the evidence. World Allergy Organ J. 2011; 4(2): 47-53.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Fingerhut L., Dolz G., de Buhr N. What is the evolutionary fingerprint in neutrophil granulocytes? Int. J. Mol. Sci. 2020; 21(12): 4523-32.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Aratani Y. Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function. Arch. Biochem. Biophys. 2018; 640: 47-52.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Bylund J., Brown K.L., Movitz C. et al. Intracellular generation of superoxide by the phagocyte NADPH oxidase: How, where, and what for? Free Rad. Biol. and Med. 2010; 49(12): 1834-45.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>O'Mahony L., Akdis M., Akdis C.A. Regulation of the immune response and inflammation by histamine and histamine receptors. J. Allergy Clin. Immunol. 2011; 128(6): 1153-62.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Просекова Е.В., Турянская А.И., Сабыныч В.А. Оценка системы интерлейкина-17 у детей с аллергической бронхиальной астмой. Тихоокеанский медицинский журнал 2018; 4: 37-40. [Prosekova E.V., Turyanskaya A.I., Sabynych V.A. Assessment of interleukin-17 system in children with allergic bronchial asthma. Pacific Medical Journal 2018; 4: 37-40. (In Russ.)].</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Alcaniz L., Vega A., Chacon P. et al. Histamine production by human neutrophils. FASEB J. 2013; 27(7): 2902-10.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Smuda C., Wechsler J.B., Bryce P.J. TLR-induced activation of neutrophils promotes histamine production via a PI3 kinase dependent mechanism. Immunol. Lett. 2011; 141(1): 102-8.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Branco A.C.C.C., Yoshikawa F.S.Y., Pietrobon A.J. et al. Role of Histamine in Modulating the Immune Response and Inflammation. Mediators Inflamm. 2018; 2018: 9524075.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Jutel M., Blaser K., Akdis C.A. The role of histamine in regulation of immune responses. Chem. Immunol. Allergy 2006; 91: 174-87.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Ciz M., Lojek A. Modulation of neutrophil oxidative burst via histamine receptors. Br.J. Pharmacol. 2013; 170(1): 17-22.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Flamand N., Plante H., Picard S. et al. Histamine-induced inhibition of leukotriene biosynthesis in human neutrophils: involvement of the H2 receptor and cAMP. Br.J. Pharmacol. 2004; 141(4): 552-61.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Jancinova V., Drabikova K., Nosal' R. et al. Extra- and intracellular formation of reactive oxygen species by human neutrophils in the presence of pheniramine, chlorpheniramine and brompheniramine. Neuro Endocrinol. Lett. 2006; 27(2): 141-3.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Scadding G. Predicting and establishing the clinical efficacy of a histamine H1- receptor antagonist: desloratadine, the model paradigm. Clin. Drug Invest. 2005; 25: 153-64.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Chen Y., Junger W.G. Measurement of oxidative burst in neutrophils. Methods Mol. Biol. 2012; 844: 115-24.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Плехова Н.Г., Сомова Л.М., Крылова Н.В. и др. Биохимические маркеры цитопатогенности вирусов в макрофагах. Прикладная биохимия и микробиология 2013; 49(1): 72-84.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Walrand S., Valeix S., Rodriguez C. et al. Flow cytometry study of polymorphonuclear neutrophil oxidative burst: a comparison of three fluorescent probes. Clin. Chim. Acta 2003; 331(1-2): 103-10.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Kowaltowski A.J. Strategies to detect mitochondrial oxidants. Redox Biol. 2019; 21: 101065.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Reenstra W.W., Crothers J.Jr., Forte J.G. The conformation of H.,K-ATPase determines the nucleoside triphosphate (NTP) selectivity for active proton transport. Biochemistry 2007; 46(35): 10145-52.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Borregaard N., Sоrensen O.E., Theilgaard-Monch K. Neutrophil granules: a library of innate immunity proteins. Trends Immunol. 2007; 28(8): 340-5.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Деев Р.В., Билялов А.И., Жампеисов Т.М. Современные представления о клеточной гибели. Гены &amp; Клетки 2018; XIII(1): 6-19.</mixed-citation></ref></ref-list></back></article>
